Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-May-24 4:40 PM View:  | BioMarin Pharmaceutical Inc. (BMRN) | 02-May-24 | Sale | 5,000 | $82.91 | $414,550.00 | (7%) 71.77K to 66.77K | |
| 06-May-24 4:40 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Apr-24 | Grant | 300 | $68.65 | $20,593.80 | < 1% 71.47K to 71.77K | |
| 19-Mar-24 8:36 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-24 | Payment of Exercise | 22,580 | $83.87 | $1,893,780.00 | (24%) 94.05K to 71.47K | (< 1%) |
| 07-Mar-24 5:32 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 05-Mar-24 | Market Sale | 4,000 | $87.07 | $348,280.00 | (4%) 98.05K to 94.05K | 3% |
| 29-Feb-24 5:12 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 27-Feb-24 | Grant | 37,243 | -- | -- | 61% 60.8K to 98.05K | |
| 20-Sep-23 8:06 PM View: | Nektar Therapeutics (NKTR) | 18-Sep-23 | Sale | 4,359 | $0.69 | $3,007.71 | (11%) 38.51K to 34.15K | |
| 17-Aug-23 3:57 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 16-Aug-23 | Sale | 5,000 | $90.00 | $450,000.00 | (8%) 65.8K to 60.8K | |
| 17-Aug-23 3:57 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 28-Apr-23 | Grant | 318 | $66.88 | $21,267.20 | < 1% 65.49K to 65.8K | |
| 17-Mar-23 9:16 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 16-Mar-23 | Payment of Exercise | 20,510 | $93.41 | $1,915,840.00 | (24%) 86.0K to 65.49K | |
| 17-Mar-23 9:16 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-23 | Grant | 10,110 | -- | -- | 13% 79.86K to 89.97K | |
| 17-Mar-23 9:16 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-23 | Payment of Exercise | 3,971 | $87.74 | $348,416.00 | (4%) 89.97K to 86.0K | |
| 02-Mar-23 4:09 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 28-Feb-23 | Grant | 38,769 | -- | -- | 94% 41.09K to 79.86K | |
| 27-Jan-23 9:35 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 25-Jan-23 | Option Exercise | 49,000 | $67.81 | $3,322,690.00 | 119% 41.09K to 90.09K | |
| 27-Jan-23 9:35 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 25-Jan-23 | Option Sale | 49,000 | $115.70 | $5,669,130.00 | (54%) 90.09K to 41.09K | |
| 04-Nov-22 5:25 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 02-Nov-22 | Market Sale | 3,000 | $86.12 | $258,360.00 | (7%) 44.09K to 41.09K | 2% |
| 26-Sep-22 7:25 PM View: | Nektar Therapeutics (NKTR) | 23-Sep-22 | Sale | 4,198 | $3.16 | $13,265.70 | (10%) 42.71K to 38.51K | |
| 20-Sep-22 8:41 PM View: | Nektar Therapeutics (NKTR) | 16-Sep-22 | Grant | 10,200 | -- | -- | 31% 32.51K to 42.71K | |
| 12-Aug-22 7:07 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 11-Aug-22 | Private Sale | 3,000 | $95.62 | $286,860.00 | (6%) 47.09K to 44.09K | |
| 07-Jun-22 2:46 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 03-Jun-22 | Payment of Exercise | 7,021 | $77.49 | $544,057.00 | (13%) 54.11K to 47.09K | (9%) |
| 31-May-22 9:29 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 26-May-22 | Sale | 1,308 | $78.94 | $103,254.00 | (2%) 55.42K to 54.11K | |
| 31-May-22 9:29 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 29-Apr-22 | Grant | 340 | $62.41 | $21,218.40 | < 1% 55.08K to 55.42K | |
| 14-Apr-22 7:54 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 13-Apr-22 | Market Sale | 1,180 | $82.47 | $97,314.60 | (2%) 56.26K to 55.08K | (2%) |
| 31-Mar-22 9:28 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Mar-22 | Market Sale | 1,381 | $79.56 | $109,872.00 | (2%) 57.64K to 56.26K | (6%) |
| 31-Mar-22 9:28 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 29-Mar-22 | Market Sale | 1,618 | $79.43 | $128,518.00 | (3%) 59.26K to 57.64K | (6%) |
| 24-Mar-22 8:49 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 23-Mar-22 | Market Sale | 6,129 | $81.78 | $501,230.00 | (9%) 65.39K to 59.26K | (3%) |
| 24-Mar-22 8:49 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Mar-22 | Market Sale | 2,073 | $81.00 | $167,913.00 | (3%) 67.46K to 65.39K | (4%) |
| 17-Mar-22 9:11 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 16-Mar-22 | Payment of Exercise | 1,287 | $80.72 | $103,887.00 | (2%) 68.75K to 67.46K | |
| 17-Mar-22 9:11 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-22 | Grant | 11,940 | -- | -- | 18% 65.22K to 77.16K | |
| 17-Mar-22 9:11 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-22 | Payment of Exercise | 8,418 | $78.27 | $658,877.00 | (11%) 77.16K to 68.75K | |
| 10-Mar-22 5:00 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 08-Mar-22 | Grant | 9,370 | -- | -- | 17% 55.85K to 65.22K | |
| 28-Oct-21 7:48 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 26-Oct-21 | Market Sale | 2,739 | $73.60 | $201,590.00 | (5%) 58.59K to 55.85K | |
| 24-Sep-21 10:00 PM View: | Nektar Therapeutics (NKTR) | 22-Sep-21 | Grant | 10,200 | -- | -- | 39% 25.98K to 36.17K | |
| 24-Sep-21 10:00 PM View: | Nektar Therapeutics (NKTR) | 22-Sep-21 | Market Sale | 3,665 | $17.78 | $65,163.70 | (10%) 36.17K to 32.51K | |
| 28-Oct-21 7:48 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Apr-21 | Grant | 342 | $62.41 | $21,343.20 | < 1% 58.25K to 58.59K | |
| 09-Apr-21 5:57 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 08-Apr-21 | Market Sale | 1,537 | $78.81 | $121,131.00 | (3%) 59.79K to 58.25K | < 1% |
| 01-Apr-21 2:17 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Mar-21 | Market Sale | 1,652 | $74.79 | $123,553.00 | (3%) 61.44K to 59.79K | (< 1%) |
| 26-Mar-21 5:45 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 24-Mar-21 | Market Sale | 1,181 | $76.30 | $90,110.30 | (2%) 62.62K to 61.44K | 2% |
| 23-Mar-21 8:40 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Mar-21 | Payment of Exercise | 1,513 | $78.52 | $118,801.00 | (2%) 64.13K to 62.62K | (< 1%) |
| 19-Mar-21 9:01 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 18-Mar-21 | Market Sale | 1,308 | $77.99 | $102,011.00 | (2%) 65.44K to 64.13K | < 1% |
| 17-Mar-21 9:27 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 16-Mar-21 | Payment of Exercise | 1,287 | $77.21 | $99,369.30 | (2%) 66.73K to 65.44K | |
| 17-Mar-21 9:27 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-21 | Grant | 10,720 | -- | -- | 17% 61.28K to 72.0K | |
| 17-Mar-21 9:27 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-21 | Payment of Exercise | 5,273 | $78.39 | $413,350.00 | (7%) 72.0K to 66.73K | |
| 15-Oct-20 7:17 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 14-Oct-20 | Market Sale | 2,121 | $79.91 | $169,489.00 | (3%) 63.4K to 61.28K | (3%) |
| 30-Sep-20 7:03 PM View: | Nektar Therapeutics (NKTR) | 28-Sep-20 | Market Sale | 3,250 | $17.25 | $56,062.50 | (11%) 29.23K to 25.98K | (7%) |
| 24-Sep-20 9:35 PM View: | Nektar Therapeutics (NKTR) | 22-Sep-20 | Grant | 9,100 | -- | -- | 45% 20.13K to 29.23K | |
| 21-Sep-20 8:58 PM View: | Nektar Therapeutics (NKTR) | 21-Sep-20 | Market Sale | 2,250 | $19.74 | $44,415.00 | (10%) 22.38K to 20.13K | 7% |
| 23-Jun-20 7:24 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 19-Jun-20 | Option Exercise | 15,000 | $63.10 | $946,500.00 | 24% 63.4K to 78.4K | |
| 23-Jun-20 7:24 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 19-Jun-20 | Market Option Sale | 15,000 | $124.00 | $1,860,000.00 | (19%) 78.4K to 63.4K | |
| 23-Jun-20 7:24 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Apr-20 | Grant | 338 | $62.59 | $21,154.10 | < 1% 63.06K to 63.4K | |
| 09-Apr-20 7:58 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 08-Apr-20 | Market Sale | 2,407 | $79.98 | $192,512.00 | (4%) 65.47K to 63.06K | (3%) |